Mirati Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:MRTX Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
16 Jan 24	SellUS$94,255	James Christensen	Individual	1,597	US$59.02
16 Jan 24	SellUS$94,255	Benjamin Hickey	Individual	1,597	US$59.02
08 Jan 24	SellUS$123,143	Benjamin Hickey	Individual	2,090	US$58.92
04 Jan 24	SellUS$90,038	James Christensen	Individual	1,531	US$58.81
18 Dec 23	SellUS$137,253	James Christensen	Individual	2,387	US$57.50
13 Dec 23	SellUS$125,807	Benjamin Hickey	Individual	2,220	US$56.67
08 Sep 23	SellUS$85,084	James Christensen	Individual	2,388	US$35.63
11 Aug 23	BuyUS$299,990	Faheem Hasnain	Individual	10,791	US$27.80
11 Aug 23	BuyUS$33,400,032	Tavistock Life Sciences	Company	1,201,440	US$27.80
11 Aug 23	BuyUS$1,599,417	MVA Associates, LLC	Company	57,533	US$27.80
02 Jun 23	SellUS$172,218	Laurie Stelzer	Individual	4,647	US$37.06
24 May 23	SellUS$28,035	James Christensen	Individual	619	US$45.29

Insider Trading Volume

Insider Buying: MRTX insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of MRTX?
Owner Type	Number of Shares	Ownership Percentage
State or Government	20,048	0.0241%
Private Companies	289,358	0.347%
Individual Insiders	627,529	0.753%
VC/PE Firms	6,337,406	7.6%
Hedge Funds	20,832,159	25%
Institutions	55,237,641	66.3%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 21.8%.

Top Shareholders

Top 25 shareholders own 95.22% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
10.5%	EcoR1 Capital, LLC	7,396,979	US$434.2m	28.7%	11.41%
9.65%	RTW Investments, LP	6,768,514	US$397.3m	51.3%	6.36%
9.5%	Avoro Capital Advisors LLC	6,666,666	US$391.3m	20%	6.29%
9.03%	Tavistock Life Sciences	6,337,406	US$372.0m	0%	15.02%
8.13%	The Vanguard Group, Inc.	5,699,632	US$334.6m	14.5%	0.01%
5.05%	BlackRock, Inc.	3,544,311	US$208.1m	6.82%	no data
4.73%	Wellington Management Group LLP	3,319,922	US$194.9m	-2.02%	0.03%
3.91%	State Street Global Advisors, Inc.	2,745,968	US$161.2m	6.36%	0.01%
3.47%	T. Rowe Price Group, Inc.	2,433,029	US$142.8m	36.9%	0.01%
3.39%	Morgan Stanley, Investment Banking and Brokerage Investments	2,378,469	US$139.6m	-14.8%	0.02%
2.89%	Artal Group S.A.	2,024,226	US$118.8m	-1.51%	3.51%
2.79%	OrbiMed Advisors LLC	1,959,050	US$115.0m	114%	1.7%
2.38%	Paradigm Biocapital Advisors LP	1,668,116	US$97.9m	15.5%	4.76%
2.18%	FMR LLC	1,527,739	US$89.7m	1,130%	0.01%
2.14%	Camber Capital Management LP	1,500,000	US$88.1m	-16.7%	2.82%
2.01%	Baker Bros. Advisors LP	1,409,784	US$82.8m	0%	0.9%
1.94%	Armistice Capital LLC	1,364,098	US$80.1m	-65.7%	2.07%
1.68%	Adage Capital Management, L.P.	1,175,000	US$69.0m	0%	0.14%
1.61%	Citadel Advisors LLC	1,131,438	US$66.4m	135%	0.07%
1.61%	Rock Springs Capital Management LP	1,131,207	US$66.4m	0.85%	1.67%
1.48%	Fiera Capital Corporation	1,038,836	US$61.0m	50.1%	0.14%
1.43%	Farallon Capital Management, L.L.C.	1,001,000	US$58.8m	0%	0.4%
1.27%	Candriam, société en commandite par actions	893,763	US$52.5m	2.29%	0.16%
1.26%	Geode Capital Management, LLC	881,226	US$51.7m	15.3%	no data
1.13%	Franklin Resources, Inc.	795,730	US$46.7m	23%	0.02%